Consider the Role of Semaglutide for Chronic Kidney Disease

November 2024

You’ll hear buzz about semaglutide for chronic kidney disease (CKD).

We know that some injectable GLP-1 agonists (dulaglutide, liraglutide, semaglutide) may slow CKD progression.

But previous studies either didn’t focus on CKD and diabetes together...or benefits in CKD were only secondary outcomes.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote